Vandetanib for the Treatment of Symptomatic or Progressive...

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

Thornton, K., Kim, G., Maher, V. E., Chattopadhyay, S., Tang, S., Moon, Y. J., Song, P., Marathe, A., Balakrishnan, S., Zhu, H., Garnett, C., Liu, Q., Booth, B., Gehrke, B., Dorsam, R., Verbois, L., G
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-12-0411
Date:
July, 2012
File:
PDF, 355 KB
english, 2012
Conversion to is in progress
Conversion to is failed